Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report for South Carolina by County

Lung & Bronchus (Late Stage^), 2017-2021

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Name

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.


Other Notes


Line by Line Interpretation of the Report


South Carolina6


US (SEER+NPCR)1


Abbeville County6


Aiken County6


Allendale County6


Anderson County6


Bamberg County6


Barnwell County6


Beaufort County6


Berkeley County6


Calhoun County6


Charleston County6


Cherokee County6


Chester County6


Chesterfield County6


Clarendon County6


Colleton County6


Darlington County6


Dillon County6


Dorchester County6


Edgefield County6


Fairfield County6


Florence County6


Georgetown County6


Greenville County6


Greenwood County6


Hampton County6


Horry County6


Jasper County6


Kershaw County6


Lancaster County6


Laurens County6


Lee County6


Lexington County6


Marion County6


Marlboro County6


McCormick County6


Newberry County6


Oconee County6


Orangeburg County6


Pickens County6


Richland County6


Saluda County6


Spartanburg County6


Sumter County6


Union County6


Williamsburg County6


York County6




Notes:
Created by statecancerprofiles.cancer.gov on 10/10/2024 10:00 pm.

State Cancer Registries may provide more current or more local data.
† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Φ Rural-Urban Continuum Codes provided by the USDA.
Source: SEER and NPCR data. For more specific information please see the table.

Data for the United States does not include data from Indiana.
Data for the United States does not include Puerto Rico.

When displaying county information, the CI*Rank for the state is not shown because it's not comparable. To see the state CI*Rank please view the statistics at the US By State level.